Catalyst Wire Dossier Catalyst Wire Dossier

Molgramostim

granulocyte-macrophage colony-stimulating factor (GM-CSF) · Savara Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Molgramostim, covering 2017-02-23 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Molgramostim Nebulizer Solution Expanded Access Program Protocol

See pricing